Spartalizumab in metastatic, well/poorly-differentiated neuroendocrine neoplasms

Title
Spartalizumab in metastatic, well/poorly-differentiated neuroendocrine neoplasms
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume -, Issue -, Pages -
Publisher
Bioscientifica
Online
2021-01-22
DOI
10.1530/erc-20-0382

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation